These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25057773)

  • 1. Clarithromycin-Induced Torsades de Pointes.
    Chang NL; Shah P; Bikkina M; Shamoon F
    Am J Ther; 2016; 23(3):e955-6. PubMed ID: 25057773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clarithromycin induced torsade de pointes.
    Hensey C; Keane D
    Ir J Med Sci; 2008 Mar; 177(1):67-8. PubMed ID: 17618400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Torsades de pointes following clarithromycin treatment.
    Gysel M; Vieweg WV; Hasnain M; Hancox JC; Kunanithy V; Baranchuk A
    Expert Rev Cardiovasc Ther; 2013 Nov; 11(11):1485-93. PubMed ID: 24147515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Torsades de pointes due to drug interaction between disopyramide and clarithromycin.
    Choudhury L; Grais IM; Passman RS
    Heart Dis; 1999; 1(4):206-7. PubMed ID: 11720625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QT prolongation and Torsades de Pointes associated with clarithromycin.
    Lee KL; Jim MH; Tang SC; Tai YT
    Am J Med; 1998 Apr; 104(4):395-6. PubMed ID: 9576415
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clarithromycin-induced torsades de pointes].
    Yamaguchi S; Kaneko Y; Yamagishi T; Ohyama Y; Amano M; Arai M; Nakamura T; Hasegawa A; Kurabayashi M
    Nihon Naika Gakkai Zasshi; 2003 Jan; 92(1):143-5. PubMed ID: 12652715
    [No Abstract]   [Full Text] [Related]  

  • 7. Clarithromycin associated with torsades de pointes.
    Kamochi H; Nii T; Eguchi K; Mori T; Yamamoto A; Shimoda K; Ibaraki K
    Jpn Circ J; 1999 May; 63(5):421-2. PubMed ID: 10943628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrolides use and the risk of sudden cardiac death.
    Li X; Wang M; Liu G; Zhou L; Wang Z; Li C
    Expert Rev Anti Infect Ther; 2016 Jun; 14(6):535-7. PubMed ID: 27086751
    [No Abstract]   [Full Text] [Related]  

  • 9. Azithromycin-induced torsade de pointes.
    Huang BH; Wu CH; Hsia CP; Yin Chen C
    Pacing Clin Electrophysiol; 2007 Dec; 30(12):1579-82. PubMed ID: 18070319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Torsades de pointes induced by the concomitant use of ivabradine and azithromycin: an unexpected dangerous interaction.
    Cocco G; Jerie P
    Cardiovasc Toxicol; 2015 Jan; 15(1):104-6. PubMed ID: 25158669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac arrest and electrical storm due to recurrent torsades de pointes caused by concomitant clarithromycin, cotrimoxazole and amiodarone treatment.
    Bienias P; Ciurzyński M; Paczyńska M; Pruszczyk P
    Pol Merkur Lekarski; 2014 Nov; 37(221):285-8. PubMed ID: 25546990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Torsades de pointes ventricular tachycardia induced by clarithromycin and disopyramide in the presence of hypokalemia.
    Hayashi Y; Ikeda U; Hashimoto T; Watanabe T; Mitsuhashi T; Shimada K
    Pacing Clin Electrophysiol; 1999 Apr; 22(4 Pt 1):672-4. PubMed ID: 10234723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Torsade de pointes induced by cisapride/clarithromycin interaction.
    Piquette RK
    Ann Pharmacother; 1999 Jan; 33(1):22-6. PubMed ID: 9972380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QT prolongation and development of torsades de pointes with the concomitant administration of oral erythromycin base and quinidine.
    Lin JC; Quasny HA
    Pharmacotherapy; 1997; 17(3):626-30. PubMed ID: 9165570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Torsades de pointes in two chronic renal failure patients treated with cisapride and clarithromycin.
    Sekkarie MA
    Am J Kidney Dis; 1997 Sep; 30(3):437-9. PubMed ID: 9292575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Torsades de pointes induced by concomitant use of chlorpheniramine and propranolol: An unusual presentation with no QT prolongation.
    Ösken A; Yelgeç NS; Zehir R; Öz TK; Yaylacı S; Akdemir R; Gündüz H
    Indian J Pharmacol; 2016; 48(4):462-465. PubMed ID: 27756965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic agents associated with QT interval prolongation.
    Olsen KM
    J Fam Pract; 2005 Jun; Suppl():S8-S14. PubMed ID: 15938993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moxifloxacin and torsade de pointes.
    Dale KM; Lertsburapa K; Kluger J; White CM
    Ann Pharmacother; 2007 Feb; 41(2):336-40. PubMed ID: 17284508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microvolt T-wave alternans monitoring in a patient with levofloxacin-induced Torsade de Pointes.
    Sahashi Y; Takasugi N; Naruse G; Kubota T; Nishigaki K; Minatoguchi S
    J Electrocardiol; 2018; 51(1):108-110. PubMed ID: 29126547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute psychotic episode secondary to Helicobacter pylori eradication treatment.
    Fernández Martos R; Burgos García A; Froilán Torres C
    Rev Esp Enferm Dig; 2017 Feb; 109(2):168-169. PubMed ID: 28071063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.